Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TIAM2 (Rho guanine nucleotide exchange factor TIAM2) is a guanine nucleotide exchange factor (GEF) that specifically activates Ras-related C3 botulinum substrate 1 (RAC1), a Rho-like small GTPase, by stimulating the exchange of GDP for GTP and shifting RAC1 to its active, GTP-bound state. TIAM2 functions to modulate cell motility, cytoskeletal reorganization, and directional cell movement, and it plays a role in neural cell development and migration. Alternative splicing produces multiple isoforms with distinct biological effects. TIAM2 and its closely related paralog TIAM1 are involved in cancer cell invasion and metastasis. Disease associations include lymphoma and Griscelli syndrome type 3, and abnormal TIAM2 activity is linked to altered cell motility in cancer and potentially neural development disorders.
Inhibition of GEF activity (potential, for experimental inhibitors) Modulation of RAC1 activation (by affecting GDP-GTP exchange)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rho guanine nucleotide exchange factor TIAM2 (TIAM2).